Basic Information
Biopharmaceutics, Inc. Develops and Sells Feminine Hygiene Product Line, While Continuing Its DBD/Mitolactol Brain Cancer Drug Development Program.
Biopharmaceutics , Inc.
United States of America
15~50 people
--
--